Amarantus Bioscience Holdings, Inc. AMBS Company Overview 

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Amarantus Bioscience Holdings, Inc. AMBS Company Overview 

Stock Message Board http://investorshangout.com/search?q=AMBS&...mp;yt1=Go!

Amarantus Bioscience Holdings, Inc. AMBS Current Price and Quotes
0.074
Previous Close
0.059
Open
0.062

Daily Range
0.0875 - 0.0605
52wk Range
0.195 - 0.004

Volume
31,025,071
Dividend
N/A

Average Vol (3m)
3,876,839
Yield
N/A

Amarantus Bioscience Holdings, Inc. AMBS
Company Information
675 Almanor Ave.
Sunnyvale, CA 94085

Website: http://www.amarantus.com
Phone: 408-737-2734
Email: gerald@amarantus.com
Find us on:      

Amarantus Bioscience Holdings, Inc. AMBS
Amarantus BioScience, Inc. is a development-stage biotechnology company founded in January 2008. The Company is focused on developing unique products and proprietary technologies for the potential treatment and/or diagnosis of Parkinson's disease, Alzheimer's disease, Traumatic Brain Injury, Ischemic Heart Disease and other human diseases. The Company owns the intellectual property rights to Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as tr...

More >>

Amarantus Bioscience Holdings, Inc. AMBS
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001424812
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Nov 19, 2012
Incorporated In: NV, USA
Year of Inc. 2008
Employees 3 a/o Nov 19, 2012
Company Officers/Contacts
Gerald E. Commissiong CEO, President, COO
Marc E. Faerber CFO, Treasurer, Secretary
John W. Commissiong CSO
Company Directors
Mark Benedyk
Gerald E. Commissiong
John W. Commissiong
Robert L. Harris
Company Notes
Formerly=Amarantus Bioscience, Inc. until 4-2013
Formerly=Amarantus Biosciences, Inc. until 12-2012
Formerly=Jumpkicks, Inc. until 6-2011
Service Providers
Auditor/Accountant
Silberstein Ungar, PLLC
30600 Telegraph Rd.
Suite 2175
Bingham Farms, MI, 48025
United States

Legal Counsel
Sichenzia Ross Friedman Ference LLP
61 Broadway
New York, NY, 10006
United States

Investor Relations Firm
LHA Inc.
800 Third Ave.
New York, NY, 10022
United States


Amarantus Bioscience Holdings, Inc. AMBS
AMBS Security Details
Share Structure
Market Value1 $34,112,073 a/o Aug 30, 2013
Shares Outstanding 460,973,956 a/o Aug 12, 2013
Float Not Available
Authorized Shares 1,000,000,000 a/o Nov 14, 2012
Par Value  0.001
Shareholders
Shareholders of Record 64 a/o Apr 26, 2013
Corporate Actions
Ex. Date Record Date Pay Date
Dividend (0.00) Jun 14, 2011 Jun 06, 2011 Jun 13, 2011
Security Notes
Capital Change=shs increased by 25 for 1 split. Ex-date=06/14/2011. Rec date=06/06/2011. Pay date=06/13/2011.
Short Selling Data
Short Interest 700 (-99.36%)
Aug 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)
VStock Transfer

Amarantus Bioscience Holdings, Inc. AMBS Recent News


Aug 29, 2013 Amarantus CEO to Present at the 2nd Annual European Investing and Partnering Summit in Helsinki
Aug 27, 2013 Amarantus Announces Two New Independent Peer-Reviewed Publications for MANF
Aug 20, 2013 Amarantus Strengthens Balance Sheet With Preferred Stock Transaction
Aug 14, 2013 Amarantus BioScience - “Ophthalmology: MANF's Orphan Strategy Coming into Focus in Retinitis Pigmentosa”
Aug 12, 2013 Amarantus Announces Positive Orphan Data for MANF in Retinitis Pigmentosa
Aug 11, 2013 OTC Daily Alert Stock Watch - Amarantus (OTCQB: AMBS )
Aug 6, 2013 Amarantus Issues Mid-Year President's Letter to Shareholders
Jul 11, 2013 Amarantus BioScience President and CEO Publishes New Blog Entitled “#C4CT Concussion Awareness Summit - The Emergence of mTBI in the Concussion Debate”
Jun 26, 2013 Amarantus to Present at OneMedForum New York on June 27
Jun 21, 2013 Amarantus to Evaluate LymPro Test as a Diagnostic and Prognostic for Chronic Traumatic Encephalopathy

12next >

Amarantus Bioscience Holdings, Inc. AMBS Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Oct 31, 2010
Total Revenue - 224 192 -
Cost of Revenue - - - -
Gross Profit - 224 192 -
Operating Expenses
Research and Development 584 1,178 490 -
Sales, General and Admin. 3,506 2,786 924 57
Non-Recurring Items - - - -
Other - - - 1
Operating Income (4,090) (3,740) (1,223) (59)
Income From Continuing Operations
Add'l Income/Expense Items 473 315 94 -
Earnings Before Interest and Tax (3,617) (3,425) (1,128) (59)
Interest Expense 1,518 1,015 79 -
Earnings Before Tax (5,136) (4,440) (1,208) (59)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (5,136) (4,440) (1,208) (59)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (5,136) (4,440) (1,208) (59)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (5,136) (4,440) (1,208) (59)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 5

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 8

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Bryan Leon Joins Storm Properties to Elevate Acquisitions Team

Updated Category News Views 381

Storm Properties Welcomes Bryan Leon as New Hire Storm Properties Inc., recognized as a significant player in the development, ownership, and management of a variety of properties, is delighted to announce the addition of Bryan Leon to their team as Land Acquisitions Manager. This appointment comes as part of the company's ongoing strategy to strengthen its position in...

Continue Reading
Revolutionizing Trade Setups with Innovative Scanner Technology

Updated Category News Views 280

Revolutionizing Trade Setups with Innovative Scanner Technology Stock Market Guides is thrilled to introduce significant advancements to its cutting-edge stock scanner technology. The latest update empowers users by showcasing the historical track record of various trade setups it identifies, offering unparalleled insight to traders looking to enhance their market...

Continue Reading
EQT Life Sciences Champions $39 Million Investment in Aerska

Updated Category News Views 101

EQT Life Sciences Champions $39 Million Investment in Aerska Advancing RNA Therapeutics EQT Life Sciences has recently announced a significant milestone: leading a $39 million Series A financing round in Aerska. This funding will be instrumental in pushing forward Aerska’s innovative brain shuttle technology. Designed to optimize the delivery of RNA interference...

Continue Reading
NVIDIA's Anticipated Earnings Report: Key Insights for Investors

Updated Category News Views 160

Understanding NVIDIA's Upcoming Earnings Announcement NVIDIA (NASDAQ: NVDA) is set to release its much-anticipated quarterly earnings report soon. Investors are keen to understand how the company is performing and what guidance it will provide for future quarters. Analysts predict that NVIDIA will announce an earnings per share (EPS) of $0.98, which indicates the level of...

Continue Reading
Innovative Partnership Forged for Enhanced Vehicle Safety

Updated Category News Views 185

Innovative Partnership Forged for Enhanced Vehicle Safety NOVOSENSE Microelectronics, a key player in the semiconductor industry known for its high-performance analog and mixed-signal chips, is joining hands with Continental Automotive Technologies to enhance vehicle safety systems. This collaboration aims to push the envelope in developing automotive-grade sensors that...

Continue Reading